Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that ...

The London-based biotechnology company said the non-dilutive funding will support its ongoing development of its lead gene therapy, GF-1002, for the treatment of metabolic associated steatohepatitis, ...

Experiment suggests liver could be key to restarting neural activities, a discovery that could pave the way for new cardiac ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...

Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...

Milk thistle, known for its silymarin content, is celebrated for protecting the liver against damage, reducing inflammation, ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

SCB Medical College and Hospital celebrates the discharge of its second liver transplant patient, a turning point in Odisha's healthcare. Witness the vital role of living donor transplants in ...

Atorvastatin is a prescription drug used for lowering cholesterol and triglyceride levels and reducing certain heart-related ...

A low-dose triple polypill containing telmisartan, amlodipine, and indapamide led to clinically meaningful improvements in ...